According to Aeterna Zentaris's latest financial reports the company's total assets are $42.48 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $56.02 M | -30.06% |
2021-12-31 | $80.1 M | 116.46% |
2020-12-31 | $37 M | 85.2% |
2019-12-31 | $19.98 M | -20.11% |
2018-12-31 | $25.01 M | 12.69% |
2017-12-31 | $22.19 M | -29.89% |
2016-12-31 | $31.65 M | -38.52% |
2015-12-31 | $51.49 M | 8.57% |
2014-12-31 | $47.43 M | -19.87% |
2013-12-31 | $59.19 M | -12.52% |
2012-12-31 | $67.66 M | -10.22% |
2011-12-31 | $75.36 M | -1.57% |
2010-12-31 | $76.57 M | -11.23% |
2009-12-31 | $86.26 M | -20.38% |
2008-12-31 | $0.10 B | -12.18% |
2007-12-31 | $0.12 B | -44.8% |
2006-12-31 | $0.22 B | -46.76% |
2005-12-31 | $0.41 B | 44.48% |
2004-12-31 | $0.29 B | 27.38% |
2003-12-31 | $0.22 B | 8.49% |
2002-12-31 | $0.21 B | 149.11% |
2001-12-31 | $84.39 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $99.94 B | 235,142.20% | ๐จ๐ญ Switzerland |
Sanofi SNY | $139.81 B | 328,987.23% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $95.15 B | 223,877.31% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.10 B | 153.44% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.73 B | 3,979.63% | ๐บ๐ธ USA |